Lorie Harper
University of Texas at Austin, Dell Medical School · Division Chief, Maternal-Fetal Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Lorie Harper as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:12 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07165327 · Injection Ports vs Single-Use Needles for Insulin in Pregnancy: Effects on Adherence and SatisfactionUniversity of Texas at Austin · not yet recruiting · Gestatiaonl Diabetes Mellitus, Pregnancy, Diabetes in Pregnancy · principal investigator
- Ph4NCT05262738 · Misoprostol Dosing in BMI Greater Than 30University of Texas at Austin · completed · Pregnancy Related, Obesity, Labor Onset and Length Abnormalities · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:12 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:12 UTC. The ranking covers the 200 most relevant of 86 PubMed records, and a shared surname and initials can bring in a namesake. All 86 on PubMed
- Long-term patient survival in ANCA-associated vasculitis.Ann Rheum Dis · 2011713 citationsRCR 22.8
- Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.Ann Intern Med · 2009691 citationsRCR 22.3
- Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis.N Engl J Med · 2020668 citationsRCR 41.3
- Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis.J Am Soc Nephrol · 2017452 citationsRCR 17.9
- Treatment for Mild Chronic Hypertension during Pregnancy.N Engl J Med · 2022433 citationsRCR 39.2
- 401 citationsRCR 13.1
- Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up.Ann Rheum Dis · 2012293 citationsRCR 11.1
- Prospective study of TNFalpha blockade with infliximab in anti-neutrophil cytoplasmic antibody-associated systemic vasculitis.J Am Soc Nephrol · 2004249 citationsRCR 7.1
- Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial.Ann Rheum Dis · 2019177 citationsRCR 9.9
- A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis.Arthritis Care Res (Hoboken) · 2011135 citationsRCR 4.1